Secondary outcomes
ADVERSE EVENTS, SECONDARY, HYPERCALCEMIA
Our secondary outcomes included the frequency of vitamin D related adverse events and an evaluation of the feasibility of a large phase III trial. Vitamin D related adverse events were defined as: persistent hypercalcemia > 24 h without calcium administration [